## Answer
The patient's medical history and the details of his dialysis session are important to consider. The patient had a cardiac arrest immediately after his dialysis session. He had been receiving hemodialysis sessions via an arteriovenous graft for the past 7 years. His medications included calcium acetate, carvedilol, enalapril, and amlodipine, and he was also receiving ceftazidime and vancomycin. The dialysate had a sodium concentration of 140 mEq/L, potassium of 2.0 mEq/L, final buffer concentration of 36 mEq/L, and calcium of 2.0 mEq/L. 

Looking at the options, we can rule out A and B. The dialysate calcium level of 2.0 mEq/L and sodium concentration of 140 mEq/L are within the normal range and are not associated with sudden cardiac death in patients with ESRD receiving hemodialysis. 

Option E, vancomycin use, is also not typically associated with sudden cardiac death in this patient population. 

Option C, a dialysate potassium concentration of 2 mEq/L, could potentially be a risk factor. Lower dialysate potassium concentrations have been associated with a higher risk of sudden cardiac death in hemodialysis patients. However, the patient's predialysis potassium level was 5.1 mEq/L, which is within the normal range, so it's not clear that this would have been a significant risk factor in this case.

Option D, the ultrafiltration rate, is the most likely factor associated with sudden cardiac death in this case. Rapid ultrafiltration in hemodialysis (greater than 10-13 ml/kg/hour) has been associated with increased mortality and cardiovascular events, including sudden cardiac death. The patient's ultrafiltration rate was 9.8 ml/min, which is relatively high and could have contributed to his cardiac arrest.

Therefore, the answer is [D. His ultraÔ¨Åltration rate].